In September, the Royal Pharmaceutical Society (RPS), the professional leadership body for pharmacists and pharmaceutical scientists in Great Britain,
announced its proposal to transition into a Royal College.
This significant step, which came following an 18-month independent review of the RPS constitution and governance, aims to strengthen the RPS’s leadership role,
with the ultimate goal of delivering greater benefits to patients and the public.
In an exclusive interview with Pharmacy Business, Tase Oputu, chair of the RPS English Pharmacy Board, discusses the key reasons behind the proposed changes, the
potential impact on pharmacists and patients, and her personal journey as the first Black Chair of the RPS Board.
Benefits for pharmacists and patients
When asked how this transition would benefit pharmacists and patients, Tase says, “I’m excited about RPS’ proposals for change. In my view, becoming a Royal
College would elevate the status of the profession and strengthen our ability to raise the profile of pharmacy, advocate for change and advance the safe and
effective use of medicines for the benefit of patients and the public.”